Open company graph database — free web & API
Login

Noven Pharmaceuticals, Inc.

Noven製薬株式会社Alias
Ticker
—
Listed market
—
Country
Jersey
Employees (non-consolidated)
300
Related companies
2
§01

Basic information

BASIC
Head office
Miami, Florida and Jersey City, New Jersey, USA
Chief executive
Takeshi Masumoto
Employees (non-consolidated)
300 people
Employees (consolidated)
Start date
1987-01-01
End date
§02

Websites

1 DOMAINS
§03

Business

14
Research and Development of Prescription Pharmaceutical ProductsManufacturing of Transdermal PatchesMarketing and Sale of Prescription Pharmaceutical ProductsTransdermal Drug Delivery SolutionsResearch and development of prescription pharmaceutical productsManufacturing of prescription pharmaceutical productsMarketing and sale of prescription pharmaceutical productsCommercialization of transdermal drug delivery systemsDevelopment of transdermal delivery technologyXELSTRYM (dextroamphetamine transdermal system)SECUADO (asenapine transdermal system)COMBIPATCH (estradiol/norethindroneacetate transdermal system)Methylphenidate Transdermal System CIIEstradiol Transdermal System
§04

Related companies

2 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Hisamitsu Pharmaceutical Co., Inc.
Group Parent
Noven Therapeutics,LLC
Customer
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

20 EVENTS

Launch of CombiPatch ® (estradiol/norethindrone acetate transdermal system), the first combination (two-drug) patchSources

Launch of Vivelle-Dot ® (estradiol transdermal system), the world's smallest estrogen patch at the timeSources

Shire licenses Noven's Daytrana ® patch for ADHDSources

Shire and Noven launch Daytrana ®Sources

Noven acquires JDS Pharmaceuticals, expanding its portfolio and sales capabilitiesSources

Noven acquired by Hisamitsu Pharmaceuticals; public company status concludesSources

Noven reacquires DaytranaSources

Hisamitsu Carlsbad facility integrated with Noven operationsSources

Noven's Northeast operations consolidated in Empire State Building co-headquartersSources

Minivelle approved by FDASources

Noven acquires Minivelle, establishes Women's Health sales teamSources

Noven Women's Health team launches MinivelleSources

Brisdelle approved by the FDASources

Launch of BrisdelleSources

Minivelle (Estradiol Transdermal System) 0.025 Mg/Day Dose Available By Prescription In U.S. Pharmacies. UPDATE: MINIVELLE has been removed from Market. ESTRADIOL TS, the authorized generic to MINIVELLE is available.Sources

Brisdelle (paroxetine) and Pexeva (paroxetine) acquired by Sebela PharmaceuticalsSources

SECUADO (asenapine) transdermal system FDA approvalSources

Launch of SECUADOSources

Approval of XELSTRYMSources

Launch of XELSTRYMSources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑